1,579 results on '"De Bree, Remco"'
Search Results
102. Cohort profile of PLUTO: a perioperative biobank focusing on prediction and early diagnosis of postoperative complications
103. Multidisciplinary Treatment of the Neck
104. Radioguided Sentinel Lymph Node Mapping and Biopsy in Oral Cancer
105. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer
106. Intravoxel incoherent motion magnetic resonance imaging in head and neck cancer: A systematic review of the diagnostic and prognostic value
107. Management of the clinically node negative neck in squamous cell carcinoma of the maxilla
108. Predictive value of quantitative 18F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma
109. Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck
110. The Current Indications for Non-Surgical Treatment of Hypopharyngeal Cancer
111. Electrochemotherapy in the head and neck area: an addition to the treatment armamentarium
112. Reply to comment on “Sarcopenia is a prognostic factor for overall survival in elderly patients with head and neck cancer”
113. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients
114. Polymorphous adenocarcinoma of the salivary glands: reappraisal and update
115. Demographic, clinical, lifestyle-related, and social-cognitive correlates of physical activity in head and neck cancer survivors
116. Predictive factors for pharyngocutaneous fistulization after total laryngectomy: a Dutch Head and Neck Society audit
117. Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome
118. Detection of Distant Metastases in Head and Neck Cancer: Changing Landscape
119. Supplementary Table S2 from Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer
120. Supplementary Figure S1. FGFR1 protein expression and FGFR1 gene copy-numbers in HPV-positive and HPV-negative head and neck squamous cell carcinoma. from FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
121. Supplementary Table S1. Results of FGFR1 protein expression and FGFR1 gene copy-numbers in HPV-positive and HPV-negative head and neck squamous cell carcinoma. from FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
122. supplemental figure legend from FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma
123. Radiomics in Hypopharyngeal Cancer Management: A State-of-the-Art Review
124. Correction to “Ultrasound‐guided resection for squamous cell carcinoma of the buccal mucosa: A feasibility study”
125. A closer look at the resection margins of buccal mucosa cancer: Their influence on local recurrence free survival
126. Intraoperative Imaging Techniques to Improve Surgical Resection Margins of Oropharyngeal Squamous Cell Cancer: A Comprehensive Review of Current Literature
127. Neutrophil to Lymphocyte Ratio in Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
128. Deep lobe parotidectomy—why, when, and how?
129. Patients' perspective on the impact of sentinel node biopsy in oral cancer treatment
130. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer
131. Cost–utility of sentinel lymph node biopsy in cT1–T2N0 oral cancer
132. An international comparison of the management of the neck in early oral squamous cell carcinoma in the Netherlands, UK, and USA
133. The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients
134. The history of sentinel node biopsy in head and neck cancer: From visualization of lymphatic vessels to sentinel nodes
135. 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients
136. Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET–CT
137. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival
138. Evaluation of the use of freehand SPECT for sentinel node biopsy in early stage oral carcinoma
139. Contrast-enhanced perfusion magnetic resonance imaging for head and neck squamous cell carcinoma: A systematic review
140. Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck squamous cell carcinoma
141. PRAME Staining in Sinonasal Mucosal Melanoma: A Single-Center Experience
142. Ultrasound‐guided resection for squamous cell carcinoma of the buccal mucosa: A feasibility study
143. Neck and Shoulder Morbidity in Patients with Oral Cancer and Clinically Negative Node Neck Status: A Comparison between the Elective Neck Dissection and Sentinel Lymph Node Biopsy Strategies
144. Response to: Application of ultrasound-guided resections in surgical removal of squamous cell carcinoma of the tongue
145. Oligometastases in head and neck squamous cell carcinoma patients
146. HPV014 - Detection of cell-free HPV DNA by ddPCR for monitoring treatment response of head and neck squamous cell carcinoma: a systematic review
147. Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
148. Surgical options in benign parotid tumors: a proposal for classification
149. The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer
150. The adverse impact of surveillance intervals on the sensitivity of FDG-PET/CT for the detection of distant metastases in head and neck cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.